These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22519684)

  • 1. 'Do more, smoke less!' Harm reduction in action for smokers with mental health/substance use problems who cannot or will not quit.
    Baker AL; Callister R; Kelly PJ; Kypri K
    Drug Alcohol Rev; 2012 Jul; 31(5):714-7. PubMed ID: 22519684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost-Pineda K; Appleton S; Fisher M; Fox K; Gaworski CL
    Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extreme solutions for those who do not succeed to quit smoking. About smokeless tobacco and harm reduction].
    Trofor A; Eşanu V; Frăsilă EI
    Pneumologia; 2008; 57(2):105-8. PubMed ID: 18822878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smokeless tobacco: the epidemiology and politics of harm.
    Phillips CV; Heavner KK
    Biomarkers; 2009 Jul; 14 Suppl 1():79-84. PubMed ID: 19604065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being.
    Degenhardt L; Hall W
    Nicotine Tob Res; 2001 Aug; 3(3):225-34. PubMed ID: 11506766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extreme solutions for those who do not succeed to quit smoking. About smokeless tobacco and harm reduction (part II)].
    Trofor A; Eşanu V; Frasilă EL
    Pneumologia; 2008; 57(3):178-81. PubMed ID: 18998333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reduction of nicotinic risk--is it possible?].
    Dubois G
    Rev Prat; 2004 Nov; 54(17):1894-6. PubMed ID: 15655913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smokeless tobacco as a nicotine delivery device: harm or harm reduction?
    Benowitz NL
    Clin Pharmacol Ther; 2011 Oct; 90(4):491-3. PubMed ID: 21934719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco harm reduction strategies: the case for physical activity.
    deRuiter W; Faulkner G
    Nicotine Tob Res; 2006 Apr; 8(2):157-68. PubMed ID: 16766410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smokeless tobacco: a gateway to smoking or a way away from smoking.
    Melikian AA; Hoffmann D
    Biomarkers; 2009 Jul; 14 Suppl 1():85-9. PubMed ID: 19604066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Would alternate tobacco products use be better than smoking?
    Martinet Y; Bohadana A; Fagerström K
    Lung Cancer; 2006 Jul; 53(1):1-4. PubMed ID: 16690160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smokers who are also using smokeless tobacco products in the US: a national assessment of characteristics, behaviours and beliefs of 'dual users'.
    McClave-Regan AK; Berkowitz J
    Tob Control; 2011 May; 20(3):239-42. PubMed ID: 21172853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smokers' perceptions of smokeless tobacco and harm reduction.
    Sami M; Timberlake DS; Nelson R; Goettsch B; Ataian N; Libao P; Vassile E
    J Public Health Policy; 2012 May; 33(2):188-201. PubMed ID: 22377777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Snuffing out cigarette sales and the smoking deaths epidemic.
    Laugesen M
    N Z Med J; 2007 Jun; 120(1256):U2587. PubMed ID: 17589555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
    Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
    Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine interventions with comorbid populations.
    Hall SM
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S406-13. PubMed ID: 18021916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.